Newland Jason G, Gerber Jeffrey S, Weissman Scott J, Shah Samir S, Turgeon Chelsea, Hedican Erin B, Thurm Cary, Hall Matt, Courter Joshua, Brogan Thomas V, Maples Holly, Lee Brian R, Hersh Adam L
Division of Infectious Diseases, Department of Pediatrics, Children's Mercy Hospitals and Clinics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri.
Infect Control Hosp Epidemiol. 2014 Mar;35(3):265-71. doi: 10.1086/675277. Epub 2014 Jan 24.
Antimicrobial stewardship programs (ASPs) are a mechanism to ensure the appropriate use of antimicrobials. The extent to which ASPs are formally implemented in freestanding children's hospitals is unknown. The objective of this study was to determine the prevalence and characteristics of ASPs in freestanding children's hospitals.
We conducted an electronic survey of 42 freestanding children's hospitals that are members of the Children's Hospital Association to determine the presence and characteristics of their ASPs. For hospitals without an ASP, we determined whether stewardship strategies were in place and whether there were barriers to implementing a formal ASP.
We received responses from 38 (91%) of 42. Among responding institutions, 16 (38%) had a formal ASP, and 15 (36%) were in the process of implementing a program. Most ASPs (13 [81%] of 16) were started after 2007. The median number of full-time equivalents dedicated to ASPs was 0.63 (range, 0.1-1.8). The most common antimicrobials monitored by ASPs were linezolid, vancomycin, and carbapenems. Many hospitals without a formal ASP were performing stewardship activities, including elements of prospective audit and feedback (9 [41%] of 22), formulary restriction (9 [41%] of 22), and use of clinical guidelines (17 [77%] of 22). Antimicrobial outcomes were more likely to be monitored by hospitals with ASPs (100% vs 68%; P = .01), although only 1 program provided support for a data analyst.
Most freestanding children's hospitals have implemented or are developing an ASP. These programs differ in structure and function, and more data are needed to identify program characteristics that have the greatest impact.
抗菌药物管理计划(ASPs)是确保抗菌药物合理使用的一种机制。独立儿童医院中ASPs的正式实施程度尚不清楚。本研究的目的是确定独立儿童医院中ASPs的普及率及特征。
我们对儿童医院协会的42家独立儿童医院进行了电子调查,以确定其ASPs的存在情况及特征。对于没有ASPs的医院,我们确定是否有管理策略以及实施正式ASPs是否存在障碍。
我们收到了42家医院中38家(91%)的回复。在回复的机构中,16家(38%)有正式的ASPs,15家(36%)正在实施一项计划。大多数ASPs(16家中的13家[81%])于2007年后启动。专门用于ASPs的全职等效人员中位数为0.63(范围为0.1 - 1.8)。ASPs监测的最常见抗菌药物是利奈唑胺、万古霉素和碳青霉烯类。许多没有正式ASPs的医院正在开展管理活动,包括前瞻性审核与反馈(22家中的9家[41%])、处方限制(22家中的9家[41%])以及临床指南的使用(22家中的17家[77%])。有ASPs的医院更有可能监测抗菌药物使用结果(100%对68%;P = 0.01),尽管只有1个项目为数据分析师提供支持。
大多数独立儿童医院已经实施或正在制定ASPs。这些计划在结构和功能上存在差异,需要更多数据来确定产生最大影响的计划特征。